These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30703428)

  • 21. RETRACTED: MicroRNA-376b-5p targets SOX7 to alleviate ischemic brain injury in a mouse model through activating Wnt/β-catenin signaling pathway.
    Zhao B; Wang P; Yu J; Zhang Y
    Life Sci; 2021 Apr; 270():119072. PubMed ID: 33482187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RETRACTED: MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin.
    Zhang J; Liu D; Feng Z; Mao J; Zhang C; Lu Y; Li J; Zhang Q; Li Q; Li L
    Biomed Pharmacother; 2016 Feb; 77():135-41. PubMed ID: 26796277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.
    Lyv X; Wu F; Zhang H; Lu J; Wang L; Ma Y
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):41. PubMed ID: 32561925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RETRACTED: LncRNA GAS6-AS1 facilitates the progression of breast cancer by targeting the miR-324-3p/SETD1A axis to activate the PI3K/AKT pathway.
    Li S; Jia H; Zhang Z; Wu D
    Eur J Cell Biol; 2020 Nov; 99(8):151124. PubMed ID: 33223203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RETRACTED: LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis.
    Dacheng W; Songhe L; Weidong J; Shutao Z; Jingjing L; Jiaming Z
    Biomed Pharmacother; 2020 May; 125():110039. PubMed ID: 32187965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RETRACTED: Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis.
    Xia H; Jing H; Li Y; Lv X
    Biomed Pharmacother; 2018 Oct; 106():156-162. PubMed ID: 29958139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RETRACTED: Long noncoding RNA LBX2-AS1 drives the progression of hepatocellular carcinoma by sponging microRNA-384 and thereby positively regulating IRS1 expression.
    Wang Y; Zhao Y; Zhang X; Zhang A; Ma J
    Pathol Res Pract; 2020 Apr; 216(4):152903. PubMed ID: 32143907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA MT1JP acts as a tumor inhibitor via reciprocally regulating Wnt/β-Catenin pathway in retinoblastoma.
    Bi LL; Han F; Zhang XM; Li YY
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4204-4214. PubMed ID: 30024609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway.
    Cao B; Liu C; Yang G
    Biomed Pharmacother; 2018 Nov; 107():185-193. PubMed ID: 30089248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RETRACTED: Ginsenoside Rh2 inhibits proliferation but promotes apoptosis and autophagy by down-regulating microRNA-638 in human retinoblastoma cells.
    Li M; Zhang D; Cheng J; Liang J; Yu F
    Exp Mol Pathol; 2019 Jun; 108():17-23. PubMed ID: 30853612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RETRACTED: LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p.
    Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q
    Biomed Pharmacother; 2020 Feb; 122():109707. PubMed ID: 31918278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway.
    He H; Qin M
    Clin Exp Pharmacol Physiol; 2020 May; 47(5):886-891. PubMed ID: 31990064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.
    Li B; Lu Y; Wang H; Han X; Mao J; Li J; Yu L; Wang B; Fan S; Yu X; Song B
    Biomed Pharmacother; 2016 Apr; 79():93-101. PubMed ID: 27044817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
    Shang Y
    Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.
    Huang D; Bi C; Zhao Q; Ding X; Bian C; Wang H; Wang T; Liu H
    BMC Cancer; 2018 Sep; 18(1):919. PubMed ID: 30249208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RETRACTED: MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1.
    Li R; Dong B; Wang Z; Jiang T; Chen G
    Biomed Pharmacother; 2018 Jun; 102():988-995. PubMed ID: 29710554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RETRACTED: EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway.
    Ma Q; Zhang Y; Liang H; Zhang F; Liu F; Chen S; Hu Y; Jiang L; Hao Y; Li M; Liu Y
    Cancer Lett; 2018 Aug; 430():97-108. PubMed ID: 29778567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RETRACTED: Long non-coding RNA LINC00160 functions as a decoy of microRNA-132 to mediate autophagy and drug resistance in hepatocellular carcinoma via inhibition of PIK3R3.
    Zhang W; Liu Y; Fu Y; Han W; Xu H; Wen L; Deng Y; Liu K
    Cancer Lett; 2020 May; 478():22-33. PubMed ID: 32067991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.